Cargando…
P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906)
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430708/ http://dx.doi.org/10.1097/01.HS9.0000846768.44187.a7 |
| _version_ | 1784779849076834304 |
|---|---|
| author | Yoo, K. H. Gang, G. W. Yi, J. H. Kim, M. K. Kim, H. J. Kim, S.-H. Park, J. S. Lee, J.-J. Min, C.-K. Lee, J. H. Cho, D. Kim, K. |
| author_facet | Yoo, K. H. Gang, G. W. Yi, J. H. Kim, M. K. Kim, H. J. Kim, S.-H. Park, J. S. Lee, J.-J. Min, C.-K. Lee, J. H. Cho, D. Kim, K. |
| author_sort | Yoo, K. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430708 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307082022-08-31 P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) Yoo, K. H. Gang, G. W. Yi, J. H. Kim, M. K. Kim, H. J. Kim, S.-H. Park, J. S. Lee, J.-J. Min, C.-K. Lee, J. H. Cho, D. Kim, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430708/ http://dx.doi.org/10.1097/01.HS9.0000846768.44187.a7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Yoo, K. H. Gang, G. W. Yi, J. H. Kim, M. K. Kim, H. J. Kim, S.-H. Park, J. S. Lee, J.-J. Min, C.-K. Lee, J. H. Cho, D. Kim, K. P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title | P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title_full | P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title_fullStr | P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title_full_unstemmed | P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title_short | P975: INTERIM ANALYSIS OF PHASE II STUDY OF DARATUMUMAB IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA WHO RECEIVED 1 PRIOR LINE OF THERAPY (KMM1906) |
| title_sort | p975: interim analysis of phase ii study of daratumumab in combination with bortezomib and dexamethasone in patients with multiple myeloma who received 1 prior line of therapy (kmm1906) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430708/ http://dx.doi.org/10.1097/01.HS9.0000846768.44187.a7 |
| work_keys_str_mv | AT yookh p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT ganggw p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT yijh p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT kimmk p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT kimhj p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT kimsh p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT parkjs p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT leejj p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT minck p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT leejh p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT chod p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 AT kimk p975interimanalysisofphaseiistudyofdaratumumabincombinationwithbortezomibanddexamethasoneinpatientswithmultiplemyelomawhoreceived1priorlineoftherapykmm1906 |